Comparison of Buspirone and Ritaline in the treatment of ADHD

Authors
Category Primary study
Registry of TrialsIranian Registry of Clinical Trials
Year 2010
INTERVENTION: Intervention 1: Tablet Buspirone 20 mg/day as intervention group for 6 weeks. Intervention 2: Tablet Ritalin 20‐30 mg/kg/day for 6 weeks as control group. Tablet Buspirone 20 mg/day as intervention group for 6 weeks Tablet Ritalin 20‐30 mg/kg/day for 6 weeks as control group Treatment ‐ Drugs CONDITION: Disturbance of activity and attention Disturbance of activity and attention. ; Disturbance of activity and attention PRIMARY OUTCOME: Severity of ADHD. Timepoint: Week 0 (before treatment) and Weeks 3 and 6 after treatment. Method of measurement: Teacher and Parent ADHD Rating Scale. INCLUSION CRITERIA: INCLUSION CRITERIA: Diagnosis of ADHD based on DSMIV age between 6‐17 Exclusion Criteria: receiving of any psychotropics drugs during past two weeks, , serum creatinin >2, hepatic failure, presence of seizures, development of extrapyramidal signs, development of serotonin syndrome
Epistemonikos ID: 17ded16e825c8faf53247e10b4e7e7ee58fac229
First added on: Aug 22, 2024